‘Biggest challenge’ | Employees demand Ozempic - and want their bosses to pay

Surging employee demand for GLP-1 weight loss drugs like Ozempic is creating a significant cost headache for UK firms, research has found.

According to a study by Howden Employee Benefits, more than a quarter of UK employees have used a weight loss drug (26%), while two-fifths (41%) believe such medication should be covered in their company’s healthcare plan.